Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)

摘要

Background: Topical psoriasis treatment relies on a reactive rather than a long-term proactive approach to disease relapse.